Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3131 Berger Ave
Ste 200
San Diego, CA 92123Phone+1 858-244-6800Fax+1 858-244-6809
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Interventional Cardiology, 2014 - 2015
- Scripps Clinic/Scripps Green HospitalFellowship, Cardiovascular Disease, 2010 - 2013
- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2006 - 2009
- Northwestern University The Feinberg School of MedicineClass of 2006
- University of Illinois at Urbana-ChampaignB.S., Cell & Structural Biology, With honors, 1998 - 2002
Certifications & Licensure
- CA State Medical License 2010 - 2026
- TX State Medical License 2015 - 2025
- IL State Medical License 2006 - 2017
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Ruben Gittes Fellow Research Award Scripps Clinic/Scripps Green Hospital, 2013
- Fellowship Teaching Award Scripps Clinic/Scripps Green Hospital, 2011
- Resident teaching award Northwestern University Feinberg School of Medicine, 2006
Publications & Presentations
PubMed
- 27 citationsP2Y2 Nucleotide Receptor Prompts Human Cardiac Progenitor Cell Activation by Modulating Hippo Signaling.Farid G. Khalafalla, Steven Greene, Hashim Khan, Kelli Ilves, Megan M. Monsanto
Circulation Research. 2017-11-10 - 27 citationsCan Hospital Rounds With Pocket Ultrasound By Cardiologists Reduce Standard EchocardiographyHashim A. Khan, Nathan E. Wineinger, Poulina Q. Uddin, Hirsch Mehta, David Rubenson
The American Journal of Medicine. 2014-07-01 - 40 citationsIstaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na–K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?Hashim Khan, Marco Metra, John E.A. Blair, Mark Vogel, Matthew E. Harinstein
Heart Failure Reviews. 2009-02-24
Journal Articles
- Can Hospital Rounds With Pocket Ultrasound By Cardiologists Reduce Standard Echocardiography?Khan H, Wineinger NE, Uddin P, Mehta HS, Rubenson DS, Topol EJ, The American Journal of Medicine, 1/1/2014
- Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition A new promising treatment for Acute Heart Failure syndromes?Khan H, Metra M, Blair JE, Vogel M, Harinstein M, Filippatos G, Sabbah H, Valentini G, Porchet H, Gheorghiade M, Heart failure Reviews, 1/1/2009
Professional Memberships
- Member
Other Languages
- Hindi, Urdu
External Links
- FCPPhttp://fcppcoachellavalley.com/bios/hashim-khan-md-facc/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: